EP 1722777 A2 20061122 - USE OF BETA-LAPACHONE FOR THE TREATMENT OF PANCREATIC CANCER
Title (en)
USE OF BETA-LAPACHONE FOR THE TREATMENT OF PANCREATIC CANCER
Title (de)
VERWENDUNG VON BETA-LAPACHONE ZUR BEHANDLUNG VON PANGREASKARZINOMEN
Title (fr)
UTILISATION DE BETA-LAPACHONE POUR LE TRAITEMENT DU CANCINOMES PANCREATIQUES
Publication
Application
Priority
- US 2005005648 W 20050218
- US 54595004 P 20040220
Abstract (en)
[origin: WO2005082359A2] The present invention provides for methods that utilize agents effective in the treatment of pancreatic cancer and pre-cancerous pancreatic cancer conditions. Moreover, the present invention provides agents capable of acting as an inhibitor of cell proliferation in pancreas cells.
IPC 8 full level
A61K 31/352 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01)
CPC (source: EP)
A61K 31/352 (2013.01); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 2005082359A2
Citation (examination)
- WO 2005082354 A1 20050909 - ARQULE INC [US], et al
- WILLINGHAM M.C.: "Cytochemical methods for the detection of apoptosis", J. HISOTCHEM. CYCTOCHEM., vol. 47, no. 9, 1999, pages 1101 - 1109
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005082359 A2 20050909; WO 2005082359 A3 20051110; CA 2555950 A1 20050909; EP 1722777 A2 20061122; EP 2033638 A2 20090311; JP 2007523193 A 20070816
DOCDB simple family (application)
US 2005005648 W 20050218; CA 2555950 A 20050218; EP 05723509 A 20050218; EP 08164574 A 20050218; JP 2006554305 A 20050218